Skip to main content
OpenTrials

Clinical trial condition

Idiopathic Pulmonary Fibrosis

Explore clinical trials studying Idiopathic Pulmonary Fibrosis. Study availability and eligibility vary by location and protocol.

330 public trials 44 recruiting studies
Refine in advanced search Browse all conditions

Idiopathic Pulmonary Fibrosis trial results

Completed

GKT137831 in IPF Patients With Idiopathic Pulmonary Fibrosis

NCT03865927

Conditions
Idiopathic Pulmonary Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +2 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Tulane University Medical Center New Orleans, Louisiana, United States
  • University of Michigan Medical Center Ann Arbor, Michigan, United States
  • Temple University Medical Center Philadelphia, Pennsylvania, United States
View Trial Details
Completed

Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis

NCT04708782

Conditions
Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease, Lung Diseases, +3 more
Locations
  • The University of Alabama at Birmingham Birmingham, Alabama, United States
  • Banner University Medical Center-Phoenix Phoenix, Arizona, United States
  • Arizona Pulmonary Specialists, Ltd. Phoenix, Arizona, United States
  • St. Joseph's Hospital and Medical Center - Norton Thoracic Institute Phoenix, Arizona, United States
View all 98 locations
View Trial Details
Completed

Study of Oral Epigallocatechin-3-gallate (EGCG) in IPF Patients

NCT05195918

Conditions
Idiopathic Pulmonary Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +2 more
Locations
  • UCSF Parnassus San Francisco, California, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • University of Michigan Ann Arbor, Michigan, United States
  • Weill Cornell Medicine New York, United States
View Trial Details
Completed

Prospective Treatment Efficacy in IPF Using Genotype for Nac Selection (PRECISIONS) Trial

NCT04300920

Conditions
Fibrosis, Idiopathic Pulmonary Fibrosis, Lung Diseases, +5 more
Locations
  • University of Arizona Tucson, Arizona, United States
  • University of Southern California Los Angeles, California, United States
  • Stanford University Stanford, California, United States
  • University of Colorado Aurora, Colorado, United States
View all 25 locations
View Trial Details
Completed

A Clinical Study to Evaluate the Efficacy and Safety of REGEND001 Cell Therapy on Idiopathic Pulmonary Fibrosis (IPF)

NCT06081621

Conditions
Idiopathic Pulmonary Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +2 more
Locations
  • Peking Union Medical College Hospital, Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China
  • The Second Affiliated Hospital of Xiamen Medical College Xiamen, Fujian, China
  • Ruijin Hospital, Shanghai Jiaotong University School Of Medicine Shanghai, Shanghai Municipality, China
  • Renji Hospital, Shanghai Jiaotong University School Of Medicine Shanghai, Shanghai Municipality, China
View Trial Details

Related conditions